ATLANTIC AMERICAN CORP (AAME)
NASDAQFinancialsInsurance - LifeSnapshot 2026-09-15
$1.290.00%
Close 2026-09-15 · 1-day change
NASDAQFinancialsInsurance - LifeSnapshot 2026-09-15
Research Workspace
Put AAME beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Maintain positive operating cash flow near $9.3M quarterly: OCF -0.7M vs 9.3M target.
View ThesisRevenue growth is accelerating — up about 12% over the past year.
View GrowthManagement screens weak on capital allocation, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 63% in its worst 12-month stretch.
View RiskAAME's growth has to keep compounding to justify the price. Recent financial performance dropped from the robust 91st to the 20th percentile of its sector. Revenue growth is weak, and the last quarter missed expectations. AAME trades at 0.2× price-to-book versus a 1.3× peer median. The price reflects less growth than we forecast, indicating modest expectations. The primary risk is the delisting notice from Nasdaq, which jeopardizes compliance with listing requirements. Our read remains broken.
Trailing returns as of 2026-09-15. AAME is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare AAME with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AAME Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 5 valuation methods, at three horizons. As of 2026-09-15. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Life & Health Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put AAME next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Compliance with Nasdaq listing requirements
Delisting notice jeopardizes compliance with Nasdaq requirements.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Non-compliance notice may affect investor confidence.